Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway

Tesio at al. identify a novel pathway controlled by the tumor suppressor and deubiquitinase cylindromatosis (CYLD), which is involved in the regulation of hematopoietic stem cell quiescence and repopulation potential.